Cargando…

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients—Authors´ Reply

Detalles Bibliográficos
Autores principales:	Stumpf, Julian, Hugo, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547805/ https://www.ncbi.nlm.nih.gov/pubmed/34723235 http://dx.doi.org/10.1016/j.lanepe.2021.100244

Ejemplares similares

A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse
por: Westhoff, Timm H., et al.
Publicado: (2021)

Humoral response after SARS-CoV-2 booster vaccination in haemodialysis patients with and without prior infection
por: Füessl, Louise, et al.
Publicado: (2022)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)
por: Hasmann, Sandra, et al.
Publicado: (2021)

Humoral response to SARS-CoV-2 vaccination in haemodialysis patients and a matched cohort
por: Zhao, Tianchen, et al.
Publicado: (2022)

Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients
por: De Vriese, An S, et al.
Publicado: (2021)

Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
por: Mairhofer, Mario, et al.
Publicado: (2021)

SARS CoV-2 seropositivity in haemodialysis patients
por: Toapanta, Nestor, et al.
Publicado: (2022)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
por: Strengert, Monika, et al.
Publicado: (2021)

Anti-SARS-CoV-2 Revaccination Success in Kidney Transplant Recipients With No Initial Humoral Response Is Linked to Primary Vaccine Type
por: Stumpf, Julian, et al.
Publicado: (2022)

Waning humoral immune responses to inactivated SARS-CoV-2 vaccines in patients with severe liver disease
por: Chen, Zhiwei, et al.
Publicado: (2022)

Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients
por: Lamy, Gaspard, et al.
Publicado: (2021)

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
por: Chen, Zhiwei, et al.
Publicado: (2022)

Humoral Immune Response to BBV152 (Covaxin) SARS-CoV-2 Vaccine in Patients on Hemodialysis
por: Vijayaraghavan, Radha, et al.
Publicado: (2023)

SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)

Author’s reply to the Letter to the Editor “The study of olfactory dysfunction in SARS-CoV-2 variants”
por: Hintschich, Constantin A., et al.
Publicado: (2022)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP()
por: Zúñiga, José, et al.
Publicado: (2021)

Newborns’ passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy
por: Gloeckner, Stefan, et al.
Publicado: (2022)

Long‐term effects of homologous and heterologous SARS‐CoV‐2 vaccination on humoral and cellular immune responses
por: Hollstein, Moritz M., et al.
Publicado: (2022)

Study authors don’t consider waning SARS-CoV-2 immunity after vaccination in their model
por: Doidge, James C., et al.
Publicado: (2022)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis
por: Karakizlis, Hristos, et al.
Publicado: (2022)

Prolonged detection of SARS-CoV-2 RNA in chronic haemodialysis patients
por: Ribitsch, Werner, et al.
Publicado: (2021)

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone
por: Cheng, Chongsheng, et al.
Publicado: (2022)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply
por: Franchini, Massimo, et al.
Publicado: (2023)

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story – Authors' reply
por: Ozonoff, Al, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
por: Alexander, James L, et al.
Publicado: (2021)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals – Authors' reply
por: Lalvani, Ajit, et al.
Publicado: (2022)

SARS-CoV-2 shedding and infectivity – Authors' reply
por: Zhou, Fei, et al.
Publicado: (2020)

Invisible spread of SARS-CoV-2 – Authors' reply
por: Kucharski, Adam J, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain – Authors' reply
por: Pollán, Marina, et al.
Publicado: (2020)

Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients
por: Aleman, Adolfo, et al.
Publicado: (2022)

128 days of SARS-CoV-2 viral shedding in a haemodialysis patient
por: Heylen, Line, et al.
Publicado: (2021)

Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patients
por: Chimon, Alice, et al.
Publicado: (2022)

Authors’ response: Plenty of coronaviruses but no SARS-CoV-2
por: Reusken, Chantal B, et al.
Publicado: (2020)

Humoral response to vaccination against SARS-CoV-2 in patients undergoing maintenance hemodialysis
por: Delgado Ureña, Ana, et al.
Publicado: (2023)

Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients
por: Oreja-Guevara, Celia, et al.
Publicado: (2022)

Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
por: Anft, Moritz, et al.
Publicado: (2022)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

Reply to the letter to the editor: “impact of SARS-CoV-2 vaccines on the nervous system”
por: Corrêa, Diogo Goulart, et al.
Publicado: (2022)

Reply to: Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations exclude differentials
por: Kania, Karolina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_18el53p03bk8tl8pur0marlboe